BMY vs PFE
Bristol Myers Squibb vs Pfizer Inc. — AI-powered side-by-side comparison
| Metric | BMY | PFE |
|---|---|---|
| AI Score | 70 | 68 |
| Price | $57.56 | $24.19 |
| P/E Ratio | 19.93× | 18.44× |
| ROE | 41.6% | 8.4% |
| Revenue Growth YoY | 1.8% | 1.4% |
| Gross Margin | 53.7% | 74.8% |
| Debt / Equity | 2.44× | 0.75× |
| Dividend Yield | 4.3% | 7.1% |
| RSI (14) | 53.8 | 44.8 |
| Beta | 0.235 | 0.2851 |
| Expected Upside | +4.6% | +7.7% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
PFE Full Analysis